SCHEMBL29800882

SCHEMBL29800882

CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ GRIN2D O15399 1/20 0.46
▸ GRIN3B O60391 1/20 0.46
▸ GRIN1 Q05586 1/20 0.46
▸ GRIN2A Q12879 1/20 0.46
▸ GRIN2B Q13224 1/20 0.46
▸ GRIN2C Q14957 1/20 0.46
▸ GRIN3A Q8TCU5 1/20 0.46
▸ BACE1 P56817 1/20 0.42
▸ ENPEP Q07075 5/20 0.40
▸ TASP1 Q9H6P5 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ PTPN1 P18031 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30661870 0.86 ENPEP (0.47) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL30661869 0.84 ENPEP (0.43) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL30964331 0.84 GRIN2D (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL30512699 0.83 GRIN2D (0.52) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL30719869 0.82 GRIN2D (0.49) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL30963041 0.82 BACE1 (0.58) BACE1ENPEP
SCHEMBL29827042 0.81 BACE1 (0.44) BACE1ENPEPTASP1RXFP1
SCHEMBL31186831 0.81 GRIN2D (0.48) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL31575680 0.81 GRIN2D (0.49) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL29815405 0.81 GRIN2D (0.49) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109422799-B Docetaxel liver cancer-resisting targeted prodrug and medicinal application thereof 复旦大学 2022-07-29 — — CN claimed
CN-109422799-B Docetaxel liver cancer-resisting targeted prodrug and medicinal application thereof 复旦大学 2022-07-29 — — CN disclosed
Send feedback